HVO – DHL focuses on sustainable transportation of pharmaceutical products for Alexion in Ireland and Europe.
This partnership fits seamlessly into the DHL Group’s sustainability strategy, which aims to reduce all logistics-related emissions to net-zero by 2050.
- Partnership reduces Greenhouse Gas (GHG) emissions from road transportation by up to 90 percent while switching from diesel to hydrogenated vegetable oil (HVO)
- HVO will be used to deliver medicines to ten countries, with approximately 500 deliveries per year
- Alexion as an industry pioneer for climate-friendly pharmaceutical transportation
DHL Global Forwarding, Freight and Alexion, AstraZeneca Rare Disease, are strengthening their collaboration, which began in 2015, with a pioneering step towards more sustainability. The two partners will use hydrogenated vegetable oil (HVO) as an environmentally friendly alternative to conventional diesel for the European road transport of pharmaceutical products.
The use of HVO, one of DHL’s sustainable approaches, will reduce annual Greenhouse Gas (GHG) emissions by up to 90 percent compared to diesel fuel. The initiative covers both domestic and international routes from the Dublin and Athlone facilities.
READ the latest news shaping the biofuels market at Biofuels Central
HVO – DHL focuses on sustainable transportation of pharmaceutical products for Alexion in Ireland and Europe. source